Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies.
Not yet recruiting
- Conditions
- Bone Disorder
- Interventions
- Other: Biological samplesOther: Biological
- Registration Number
- NCT06444503
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.
This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
- Children (from birth) with growth plate or bone pathology
- Patients affiliated to or benefiting from a social security scheme
- Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies :
- mastery of the French language
- Not being subject to a restriction of rights by the judicial authorities
- Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).
Exclusion Criteria
- Patients under legal protection (guardianship, curatorship or safeguard of justice)
- Pregnant or breast-feeding women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients suffering from growth plate or bone pathology Biological samples As part of their pathology, patients benefit from clinical monitoring and regular blood and urine tests. Patients suffering from growth plate or bone pathology Biological As part of their pathology, patients benefit from clinical monitoring and regular blood and urine tests.
- Primary Outcome Measures
Name Time Method Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies Day 0 and through study completion, an average of 5 years Blood and urine sampling
- Secondary Outcome Measures
Name Time Method Identification of potential markers of disease progression based on new knowledge. Day 0 and through study completion, an average of 5 years
Trial Locations
- Locations (1)
University Toulouse Hospital
🇫🇷Toulouse, France